Tag: Parliamentary Question

  • Karl McCartney – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    Karl McCartney – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Karl McCartney on 2016-02-26.

    To ask the Secretary of State for Foreign and Commonwealth Affairs, what recent assessment he has made of diplomatic and economic relations between China and the UK.

    Mr Hugo Swire

    Our relationship with China is stronger than ever. Last year’s State Visit by President Xi delivered £40bn in commercial deals, benefiting the UK economy, and establishing a new partnership to work together on global challenges. This global partnership is already delivering results, with the launch of a new visa agreement to boost tourism and business during the Secretary of State for Foreign and Commonwealth Affairs, my right Hon. Friend the Member for Runnymede and Weybridge (Mr Hammond’s) visit to Beijing in January. The Foreign Secretary has also intensified co-operation with China on the Syria crisis. The Chancellor of the Exchequer and First Secretary of State, my right Hon. Friend the Member for Tatton (Mr Osborne’s) visit to China last week was a further opportunity to strengthen economic co-operation bilaterally and through the G20, and encourage China to open up further to foreign investment and address over-capacity. The Government has a relationship with China which maximises the opportunities for the UK and allows frank discussion of difficult issues, such as human rights

  • Keith Vaz – 2016 Parliamentary Question to the Department of Health

    Keith Vaz – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Keith Vaz on 2016-03-24.

    To ask the Secretary of State for Health, what scientific testing Spirit Healthcare’s Empower type 2 diabetes education programme underwent for the outcomes it produces.

    Jane Ellison

    The information requested is not held centrally.

  • Tulip Siddiq – 2016 Parliamentary Question to the HM Treasury

    Tulip Siddiq – 2016 Parliamentary Question to the HM Treasury

    The below Parliamentary question was asked by Tulip Siddiq on 2016-05-04.

    To ask Mr Chancellor of the Exchequer, how many accountancy (a) practitioners and (b) firms are supervised by (i) HM Revenue and Customs and (ii) each of the other accountancy bodies; and how many such practitioners and firms have been (A) investigated for suspected money laundering and (B) struck off as a result of such investigations.

    Mr David Gauke

    There are 15 supervisors of the accountancy service provider (ASP) sector in the United Kingdom, including HM Revenue and Customs (HMRC).

    13,131 ASPs are registered with HMRC for anti-money laundering supervision. The professional accountancy bodies listed in Schedule 3 to the Money Laundering Regulations 2007 between them supervise 32,069 firms and individuals. Whilst the statistics vary between bodies as to the number of individuals supervised compared to firms, 18,872 of the 32,069 have been identified as individuals.

    HMRC does not record statistics for its investigations in a way that enables figures relating to ASPs to be separately identified. HMRC does not hold data about practitioners and firms investigated or struck off by other supervisory bodies.

  • Jim Shannon – 2016 Parliamentary Question to the Department of Health

    Jim Shannon – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2016-06-09.

    To ask the Secretary of State for Health, if he will instruct officials of his Department to continue to work with the manufacturers of Nivolumab on ensuring that patients with non-squamous non-small cell lung cancer can access that drug through the NHS.

    George Freeman

    The National Institute for Health and Care Excellence (NICE) is currently appraising nivolumab (Opdivo) for non-squamous non-small cell lung cancer.

    As part of its appraisal, the NICE has considered a patient access scheme (PAS) proposal from the manufacturer Bristol-Myers Squibb which has been agreed by Ministers. Departmental officials are open to discussing any further proposals regarding the PAS with the company.

    The NICE currently expects to publish its final guidance in September 2016.

    In the absence of the NICE guidance, it is for commissioners to make funding decisions based on the available evidence.

  • Diana Johnson – 2016 Parliamentary Question to the Department for Exiting the European Union

    Diana Johnson – 2016 Parliamentary Question to the Department for Exiting the European Union

    The below Parliamentary question was asked by Diana Johnson on 2016-09-06.

    To ask the Secretary of State for Exiting the European Union, what his policy is on future UK participation in the EU cybersecurity strategy.

    Mr David Jones

    We are leaving the EU but co-operation on security, including on cyber security, with our European and global allies will be undiminished. We will do what is necessary to keep our people safe. We are about to begin these negotiations and it would be wrong to set out unilateral positions in advance.

  • Jeremy Lefroy – 2016 Parliamentary Question to the Department of Health

    Jeremy Lefroy – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jeremy Lefroy on 2016-10-21.

    To ask the Secretary of State for Health, what plans he has to provide support to children’s hospices which extend their services for young adults.

    David Mowat

    The Department provided grant funding in 2013-16 to Together for Short Lives, the organisation supporting children’s hospices, to support the Transition Taskforce. The Taskforce provides guidance and training that supports good transitions locally between children’s and adult services for those with life-limiting conditions or needing palliative care.

    NHS England is continuing to prioritise funding for the children’s hospice grants programme at the current level. NHS England has been engaging with children’s hospices through Together for Short Lives prior to a consultation on the allocation method for the 2017-18 grant.

  • Baroness Tonge – 2015 Parliamentary Question to the Foreign and Commonwealth Office

    Baroness Tonge – 2015 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Baroness Tonge on 2015-11-09.

    To ask Her Majesty’s Government what representations they made to the government of Israel concerning the right of Palestinian Christians from the West Bank to visit Jerusalem for Christmas worship.

    Baroness Anelay of St Johns

    We have not specifically raised the issue of access for Palestinian Christians with the Israeli authorities. However the Government remains deeply concerned about restrictions on freedom of movement between the West Bank and East Jerusalem. It remains difficult for Palestinians, of all religions, to enter East Jerusalem for work, education, medical treatment or religious worship. Through our Embassy in Tel Aviv, we regularly lobby the Israeli authorities on this matter and encourage them to lift access restrictions.

  • Nicholas Soames – 2015 Parliamentary Question to the Department for Culture, Media and Sport

    Nicholas Soames – 2015 Parliamentary Question to the Department for Culture, Media and Sport

    The below Parliamentary question was asked by Nicholas Soames on 2015-12-02.

    To ask the Secretary of State for Culture, Media and Sport, what assessment his Department has made of the (a) funding of horseracing and (b) effect of Race Fields legislation in Australia.

    Tracey Crouch

    To inform work to replace the current levy system, we have commissioned an independent economic analysis of the costs and funding of horseracing. This economic analysis work will also examine relevant comparable models, including the Australian system, however any reform of the Levy will need to comply with EU law.

  • Margaret Ferrier – 2016 Parliamentary Question to the Department for Environment, Food and Rural Affairs

    Margaret Ferrier – 2016 Parliamentary Question to the Department for Environment, Food and Rural Affairs

    The below Parliamentary question was asked by Margaret Ferrier on 2016-01-13.

    To ask the Secretary of State for Environment, Food and Rural Affairs, what assessment she has made of the conclusions of the United States Environmental Protection Agency’s assessment of the neoniocotinoid imidacloprid, published on 6 January 2016.

    George Eustice

    The United States Environmental Protection Agency has published a “Preliminary Pollinator Assessment to Support the Registration Review of Imidacloprid”. The Agency aims to produce the final assessment at the end of 2016. The preliminary assessment indicates a risk to honey bees from uses of imidacloprid on cotton and some uses on citrus. Risks from use on a number of other crops were low and a shortage of data meant that the risks from use on other crops were uncertain.

    The US assessment cannot be read across to the UK situation as there are many differences in the crops, methods of applying the pesticide and environmental conditions.

    The European Food Safety Authority has begun a scientific evaluation of the risk to bees from imidacloprid, as well as two other neonicotinoids (clothianidin and thiamethoxam). The UK will participate fully in that review.

  • Julian Knight – 2016 Parliamentary Question to the Cabinet Office

    Julian Knight – 2016 Parliamentary Question to the Cabinet Office

    The below Parliamentary question was asked by Julian Knight on 2016-02-08.

    To ask the Minister for the Cabinet Office, what recent progress he has made in reducing the rate of unemployment.

    Mr Rob Wilson

    The information requested falls within the responsibility of the UK Statistics Authority. I have asked the Authority to reply.